Vertos Medical Inc. Completes Enrollment in U.S. IRB I Study of mild(R), Unveils Comprehensive Clinical Strategy

Published: Jan 21, 2010

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Medical device company Vertos Medical Inc. has announced the completion of enrollment in its post-market U.S. IRB (Institutional Review Board) I Patient Outcomes Trial, a 75-patient study of the mild* procedure. The open-label, single-arm, prospective, IRB-approved study is intended to gather patient outcomes data following treatment for symptomatic central canal spinal stenosis using proprietary mild devices. Results from the trial, which is being conducted by 14 investigators at academic and private practice settings across the United States, are expected to be published during 2010.

Back to news